RACHEL CATHERINE POWERS D.O.
Prescription History 1548793367
Internal Medicine - Pulmonary Disease in Akron, OH
NPI Status: Active since April 08, 2017
Prescription History for Informed Healthcare Decisions
When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions RACHEL CATHERINE POWERS D.O. has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.
Why This Information Matters
This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:
- Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
- Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
- Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
- Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
- Generic Name
- Umeclidinium Brm/Vilanterol Tr
- Specialty
- Student in an Organized Health Care Education/Training Program
- Times Prescribed
- 16
- Number of 30-Day Refills Prescribed
- 24
- What is this prescription used for?
- This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.
- Generic Name
- Tiotropium Br/Olodaterol Hcl
- Specialty
- Student in an Organized Health Care Education/Training Program
- Times Prescribed
- 13
- Number of 30-Day Refills Prescribed
- 13
- What is this prescription used for?
- This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.
This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.